(19)
(11) EP 4 798 706 A2

(12)

(88) Date of publication A3:
30.05.2025

(43) Date of publication:
02.09.2026 Bulletin 2026/36

(21) Application number: 24808772.8

(22) Date of filing: 28.10.2024
(51) International Patent Classification (IPC): 
C12N 9/12(2006.01)
C12N 9/80(2006.01)
C12N 9/36(2006.01)
C12P 21/02(2006.01)
(52) Cooperative Patent Classification (CPC):
C12N 9/2462; C12N 9/80; C12N 9/1247; C12P 21/02; C12R 2001/19; C12Y 207/07006; C12Y 302/01017; C12Y 305/01088
(86) International application number:
PCT/US2024/053215
(87) International publication number:
WO 2025/091009 (01.05.2025 Gazette 2025/18)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 27.10.2023 US 202363546075 P
14.03.2024 US 202463565189 P

(71) Applicant: Sutro Biopharma, Inc.
South San Francisco CA 94080 (US)

(72) Inventors:
  • GROFF, Daniel James
    south San Francisco, California 94080 (US)
  • BLAKE-HEDGES, Jacquelyn Marie
    South San Francisco, California 94080 (US)
  • FOO, Wilson Lee
    South San Francisco, California 94080 (US)
  • YUAN, Dawei
    South San Francisco, California 94080 (US)

(74) Representative: Geling, Andrea 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) OVEREXPRESSION OF LYSOZYME IN T7 RNA POLYMERASE-EXPRESSING HOST CELLS